This weight-loss drug maker's stock is up 20% this year — and Barclays sees it going higher – CNBC
Technology News
- This weight-loss drug maker’s stock is up 20% this year — and Barclays sees it going higher CNBC
- Thursday’s biggest analyst calls on Wall Street CNBC
- This video game stock could struggle after the blocking of Microsoft’s Activision Blizzard takeover, BMO says CNBC
- Barclays says there’s a big buying opportunity in Activision Blizzard after blocked Microsoft deal, sees shares rallying 30% CNBC
- One online retailer will get a sizable sales boost from Bed Bath & Beyond’s demise, Telsey Group estimates CNBC
- View Full Coverage on Google News
Source: Technology News